News for RedHill Biopharma Stock (RDHL)

RDHL Stock: Why It Substantially Increased This Week

Pulse2 • 10/19/21

RedHill Biopharma Announces Insider Buying

Accesswire • 10/18/21

RedHill Biopharma Ltd Announces New U.S. Patent for RedHill's Talicia for H.pylori

Accesswire • 10/12/21

RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034

PRNewsWire • 10/12/21

RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL

Accesswire • 10/06/21

RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements

PRNewsWire • 10/06/21

RedHill (RDHL) COVID Pneumonia Drug Meets Study Goal, Stock Up

Zacks Investment Research • 10/06/21

Why RedHill Biopharma Blasted 12% Higher Today

The Motley Fool • 10/04/21

Why Did RedHill Biopharma Shares Jump 12% Monday?

Benzinga • 10/04/21

RDHL Stock: Why It Increased Today

Pulse2 • 10/04/21

RedHill Biopharma reports 62% mortality reduction in moderately severe COVID-19 patients treated with oral opaganib in new analysis of data from global Phase 2/3 study

Proactive Investors • 10/04/21

RedHill's stock is up 7.0% as it shares new data about experimental COVID-19 drug

Market Watch • 10/04/21

RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients

Accesswire • 10/04/21

RedHill Settles Movantik Patent Litigation With Aurobindo

Benzinga • 09/23/21

RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with Aurobindo

PRNewsWire • 09/23/21

RedHill (RDHL) Down on Unsatisfactory Data From COVID-19 Study

Zacks Investment Research • 09/15/21

RedHill Biopharma accelerates US Phase 2/3 COVID-19 study of once-daily oral RHB-107 in non-hospitalized patients with South African approval

Proactive Investors • 09/14/21

Why RedHill Biopharma Stock Is Getting Crushed Today

The Motley Fool • 09/14/21

What's Happening With RedHill Biopharma's Stock On Tuesday?

Benzinga • 09/14/21

RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19 Patients

PRNewsWire • 09/14/21

RedHill Biopharma To Test Its Oral Antiviral In COVID-19 Patients In South Africa

Benzinga • 09/13/21

RHB-107 P2/3 COVID-19 Study South Africa Approval

Accesswire • 09/13/21

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

PRNewsWire • 09/13/21

RedHill's (RDHL) Opaganib Effective Against Kidney Fibrosis

Zacks Investment Research • 09/08/21

RedHill Biopharma notes study demonstrates opaganib's efficacy in significantly decreasing renal fibrosis

Proactive Investors • 09/08/21